Recurrence, Readmission, and Key Mortality Predictors in Patients with Carbapenem-Resistant Enterobacterales Infections
Diagnostics · 21.11.2025 · 15 (23) · 2957
DOI: 10.3390/diagnostics15232957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 21.11.2025. Verfasst von Bashayer Mohammed Alshehail und 22 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Practice Department, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Carbapenem-resistant Enterobacterales (CRE) are designated by the World Health Organization as critical-priority pathogens. While global outcomes are well documented, regional data from the Middle East remain limited.
Methods
We performed a retrospective cohort study of adults with confirmed CRE infections admitted to King Fahad Hospital of the University, Saudi Arabia, between 2019 and 2024. Clinical, microbiological, and therapeutic data were analyzed. Primary outcomes were infection recurrence, recurrence-related readmissions, and all-cause mortality at 14, 30, and 90 days. Predictors were assessed using univariate tests and multivariate Cox regression.
Results
Among 101 patients (mean age 65 years, 57% female), Klebsiella pneumoniae predominated (94%), with OXA-48 detected in 70%. Most infections were hospital-acquired (78%). Recurrence occurred in 16.8% of cases, with 12.9% requiring readmission. Mortality reached 22.8% at 14 days, 30.7% at 30 days, and 42.6% at 90 days. Diabetes mellitus predicted recurrence (p = 0.024). Independent predictors of 90-day mortality were pneumonia (HR 2.39, 95% CI 1.23–4.64), critical care admission (HR 6.24, 95% CI 2.44–15.97), and hypotension (HR 4.10, 95% CI 1.84–9.15). Elevated Pitt bacteremia and INCREMENT-CPE scores also stratified risk.
Conclusions
CRE infections in Saudi Arabia impose a heavy clinical burden, with high recurrence, frequent readmissions, and late mortality. Identifying drivers of recurrence and mortality highlights opportunities for targeted risk stratification. Beyond treatment choices, these findings emphasize the need for proactive surveillance, integrated stewardship, and early recognition of high-risk patients. Region-specific evidence such as this is critical to shaping infection control policies and guiding future multicenter research into novel therapeutic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy Practice Department, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.
- Infectious Disease Division, Internal Medicine Department, King Fahd University Hospital, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
- Department of Pharmaceutical Care, Northern Area Armed Forces Hospital, Hafar Al Batin 31991, Saudi Arabia.
- Department of Microbiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.
- Pharmacy Practice Department, College of Clinical Pharmacy, King Faisal University, Alahsa 31982, Saudi Arabia.
- Pharmaceutical Care Department, King Fahd University Hospital, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
ORCID-Profile: Bashayer Mohammed Alshehail, Marwan Jabr Alwezzeh, Amani Alnimr, Haytham Wali, Zainab Al Jamea, Yazed S Alsowaida, Omar Alzuwayed, Aiman El-Saed
Zitieren
APA
Alshehail, B. M., Alwezzeh, M. J., Almalki, H. H., Alnimr, A., Wali, H., Al Jamea, Z., Al Rashed, A. S., Alhajri, M., Abdulaal, H. A., Alanbari, L. A., Alsowaida, Y. S., Alamri, A., Almuthen, S., Azaiez, F., Alzahrani, S., Zakari, N., Asiri, J., Alanazi, W., Bakkar, M., …, & AlBahrani, S. (2025). Recurrence, Readmission, and Key Mortality Predictors in Patients with Carbapenem-Resistant Enterobacterales Infections. Diagnostics, 15(23), 2957. https://doi.org/10.3390/diagnostics15232957
Vancouver
Alshehail BM, Alwezzeh MJ, Almalki HH, Alnimr A, Wali H, Al Jamea Z, et al. Recurrence, Readmission, and Key Mortality Predictors in Patients with Carbapenem-Resistant Enterobacterales Infections. Diagnostics. 2025;15(23):2957. doi:10.3390/diagnostics15232957
BibTeX
@article{Alshehail2025,
author = {Alshehail, Bashayer Mohammed and Alwezzeh, Marwan Jabr and Almalki, Hussain Humaid and Alnimr, Amani and Wali, Haytham and Al Jamea, Zainab and Al Rashed, Abdullatif S and Alhajri, Mashael and Abdulaal, Hawra Abdulwahab and Alanbari, Lujain Ali and Alsowaida, Yazed S and Alamri, Abdullah and Almuthen, Sharifah and Azaiez, Faten and Alzahrani, Saeed and Zakari, Nawaf and Asiri, Jaber and Alanazi, Wafa and Bakkar, Mohanad and Alfifi, Abdulaziz and Alzuwayed, Omar and El-Saed, Aiman and AlBahrani, Salma},
title = {Recurrence, Readmission, and Key Mortality Predictors in Patients with Carbapenem-Resistant Enterobacterales Infections},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {23},
pages = {2957},
doi = {10.3390/diagnostics15232957}
}
EUVIMED